'Long-term safety of nipple sparing mastectomy in gene positive women' is a collaborative study led by the Jewish General Hospital, with SPHERE participating as a sub-site where a retrospective chart review will be used to analyze breast cancer incidence in women who have undergone risk-reducing mastectomy after being identified as carriers of BRCA1, BRCA2, PALB2, TP53, CDH1, or PTEN. The study focuses on women who undergo genetic testing, discover they carry a genetic variant linked to breast cancer, and choose to have a risk-reducing mastectomy before developing the disease. These women can undergo one of three types of mastectomy: total mastectomy, skin-sparing mastectomy, or nipple-sparing mastectomy (NSM). While NSM typically provides better cosmetic outcomes for immediate reconstruction, concerns exist about its effectiveness in risk reduction due to the potential for residual breast tissue.
Lead site: Jewish General Hospital
Principal Investigator: Stephanie M Wong, William D Foulkes
Site Investigator for Calgary: Alison Laws